Compare
Vyvgart vs. Vyvgart Hytrulo

Vyvgart (efgartigimod alfa or efgartigimod alfa-fcab) is an FDA-approved IV injection that's used to treat adults with generalized myasthenia gravis (gMG). It belongs to a drug class called neonatal Fc receptor blockers, which work by lowering harmful antibodies that interferes with communication between your nerves and muscles. The medication is given IV, typically at an infusion center, your prescriber's office, or at home. Common side effects include respiratory tract infections, headache, and urinary tract infection (UTIs).

• Generalized myasthenia gravis (gMG) in adults

• Respiratory tract infection (33%)
• Headache (32%)
• Urinary tract infection (10%)

• Infections
• Allergic reactions
• Infusion-related reactions

Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) is an injection used to treat adults with generalized myasthenia gravis (gMG). It's also FDA approved as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). The medication comes in a vial or prefilled syringe, and it's injected under your skin. Common side effects include injection site reactions and headache.

• Generalized myasthenia gravis (gMG) in adults
• Chronic inflammatory demyelinating polyneuropathy (CIDP)

gMG

• Injection site reactions (38%)
• Headache (at least 10%)

CIDP

• Injection site reactions (15%)

• Infections
• Allergic reactions
• Injection-related reactions